Navigation Links
Labopharm Appoints Dr. Claire Brulle as Senior Vice-President and Chief Medical Officer
Date:4/28/2008

- Dr. Sylvie Bouchard to Retire from Company -

LAVAL, QC, April 28 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that Claire Brulle, M.D. has been appointed Senior Vice-President and Chief Medical Officer of the Company. Incumbent Chief Medical Officer Dr. Sylvie Bouchard has retired from Labopharm Inc. to focus on her career practicing medicine.

"Dr. Brulle brings to Labopharm a proven track record in medical affairs and clinical development and an impressive portfolio of competencies ranging from global clinical development to medical support for commercial operations," said James R. Howard-Tripp, President and Chief Executive Officer, Labopharm Inc. "With extensive experience interacting with regulatory agencies in both North America and Europe and specific expertise in the area of pain therapeutics, Dr. Brulle is a strong addition to our team as we pursue our objective of commercializing multiple large market opportunity drugs."

Dr. Brulle has more than 25 years experience in the medical profession, including more than 15 years experience in the pharmaceutical industry with Pfizer Inc. During her tenure at Pfizer, Dr. Brulle held a series of increasingly senior medical roles, including lead positions for the Pain and Arthritis Franchise. Dr. Brulle received her Medical Degree from the Universite de Paris and has completed International and Leadership Development Programs from INSEAD Institute and Harvard Business School, respectively.

Mr. Howard-Tripp continued, "Dr. Bouchard's expertise and diligence has been invaluable to Labopharm's success to date. On behalf of the Company and the Board of Directors, I would like to thank her for her very significant contribution to Labopharm and wish her well as a full-time practicing physician."

Dr. Bouchard will continue to be available to Labopharm to transition the role to Dr. Brulle and will act as a consultant to the Company going
'/>"/>

SOURCE Labopharm Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Labopharm Appeals FDAs Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy
2. Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
3. Labopharms Once-Daily Tramadol Approved in South Korea and Australia
4. Labopharm to host conference call Thursday, February 21, 2008 at 8:30 a.m. (ET)
5. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
6. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
7. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
8. Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
9. Labopharm Reports Results for Third Quarter Fiscal 2007
10. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
11. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... Epidemiologists forecast an increase in the diagnosed incident ... incident cases in 2013 to 11,568 diagnosed incident cases ... 4.35%, during the forecast period. In 2023, the US ... of aGVHD in the 6MM, with 4,989 diagnosed incident ... diagnosed incident cases of aGVHD, with 704 diagnosed incident ...
(Date:7/13/2014)... decreased ability to identify odors might indicate the ... examinations of the eye could indicate the build-up ... the brain, according to the results of four ... International Conference 2014 (AAIC 2014) in Copenhagen. , ... to identify odors was significantly associated with loss ...
(Date:7/13/2014)... Wright & Schulte LLC has learned ... in July of 2015, in U.S. District Court, District ... the discovery process in the South Carolina federal ... over the multidistrict litigation (MDL). The complaints pending in ... who allege that they took the statin medication to ...
(Date:7/13/2014)... Hills, California (PRWEB) July 13, 2014 ... Danny Musico has formed a promotional partnership with Aqua ... plant based Omega-3 EPA supplement . The collaboration ... is a celebrity fitness trainer , actor, model, ... Hollywood’s go-to trainer for A-List celebrities, he has prepared ...
(Date:7/13/2014)... July 13, 2014 Hope Palliative & Hospice ... grief support group at the Tamarack Senior Living Community in ... at 10:30 A.M. on the 3rd Wednesdays of every month. ... at the Tamarack Community located at 55 S. Greeley St. ... individuals and there is no cost for the group. ...
Breaking Medicine News(10 mins):Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 2Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 3Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 4Health News:Smell and eye tests show potential to detect Alzheimer's early 2Health News:Smell and eye tests show potential to detect Alzheimer's early 3Health News:Smell and eye tests show potential to detect Alzheimer's early 4Health News:Smell and eye tests show potential to detect Alzheimer's early 5Health News:Smell and eye tests show potential to detect Alzheimer's early 6Health News:Smell and eye tests show potential to detect Alzheimer's early 7Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 2Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 3Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 4Health News:Celebrity Fitness Expert Supports Revolutionary New Health Supplement 2Health News:Hope Hospice Announces Grief Support Group at the Tamarack Senior Living Community 2
... undertake a long-term weight training program produce more ... physiologists //to understand why weight training improves muscle ... study published in the December issue of the ... different forms of growth hormone, used different testing ...
... found that young women who grow up in cities or move ... ,Princess Diana was known to suffer from this eating ... country, and moved to London as a teenager. ,Bulimia ... a routine of over-eating and vomiting or purging. This study ...
... researchers have discovered a protein interaction that may explain ... findings, published in and featured on the cover of ... the mutated Huntington’s protein interacts with another protein to ... , ,“Cholesterol is essential for promoting the connection ...
... issue of Human Gene Therapy has published the findings ... to treat erectile dysfunction.// The finding shows that gene ... gene therapy is beneficial for months, and hence could ... ,Lead author Arnold Melman, M.D., professor and ...
... told that patients undergoing chemotherapy in remote areas may be ... patient sending a text of his symptoms according to their ... of a red alert sent to medical staff, or an ... new age technology may be used along with a mobile ...
... is always the case that women would have to work ... be it in career or otherwise. This was recently reiterated ... of Physiology-Endocrinology and Metabolism”. ,According to this ... of growth hormone by women whereas men use testosterone for ...
Cached Medicine News:Health News:Varying Weight Training Intensity Ups Growth Hormone in Women 2Health News:Link Between Huntington’s and Abnormal Cholesterol Levels in Brain Establishe 2Health News:Gene Therapy May Be the Solution for Erectile Dysfunction 2
(Date:7/11/2014)... Neurelis, Inc. ("Neurelis") today announced an agreement ... held by Biotie to purchase Neurelis, clearing the way ... diazepam) for pediatric and adult epilepsy patients who experience ... Biotie has advanced the development program for NRL-1 and ... work required for NDA submission to the FDA.  Given ...
(Date:7/10/2014)... July 10, 2014  Breg, Inc., a premier ... launched the FreeRunner™ knee brace with new innovations ... patella mal-tracking return to active lifestyles.  FreeRunner,s patent-pending ... braces, providing support when patients need it most, ... don,t. Patellofemoral issues are the most ...
(Date:7/10/2014)... , July 10, 2014  BC Technical, the ... MiE America , Inc., a leading provider of ... into a long-term agreement naming BC Technical as the ... MiE and BC Technical announced today ... to establish BC Technical as the service and systems ...
Breaking Medicine Technology:Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2
... 20, 2011 Ann Arbor SPARK recently celebrated the conclusion ... and a reception.  At the Ann Arbor SPARK Boot Camp ... Boot Camp" winner, based on the quality of its investor ... engagement though the Ann Arbor SPARK Business Accelerator.   ...
... HYDERABAD, India, May 20, 2011 Neuland Laboratories Ltd., ... (APIs), complex intermediates, and contract research and manufacturing services ... results for the 2011 fiscal year (FY) ended March ... report that in fiscal year 2011, Neuland delivered on ...
Cached Medicine Technology:Brio Device Awarded Best of Ann Arbor SPARK's Boot Camp 2Neuland Labs Reports Financial Results for Fiscal Year 2011 2
The Pach IV is the premier product for cornea thickness measurement in conjunction with Glaucoma screening....
Inquire...
... Immunosorbent Assays(ELISA) is intended for the detection ... Measles Rubeola) virus in human sera. Individual ... determination of immune status. Paired sera, acute ... or a significant rise in antibody as ...
Measles IgM ELISA test is an enzyme linked immunosorbent assay (ELISA) for the detection of IgG class antibodies to Measles (Rubeola) in human serum or plasma....
Medicine Products: